Surufatinib is a novel, oral angio-immuno kinase inhibitor that selectively inhibits the tyrosine kinase activity associated…
About Sunitinib Sunitinib is an anti-cancer medication. It is a small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved…
INDICATIONS AND USAGE Erlotinib is a kinase inhibitor indicated for: · The treatment of patients with metastatic…
About Belzutifan Belzutifan is an hypoxia-inducible factor-2 alpha inhibitor. Belzutifan is used to treat von Hippel-Lindau…
About Olaparib Olaparib is a poly (ADP ribose) polymerase (PARP) inhibitor, at least before monotherapy Germline…
About Olaparib Olaparib is a poly (ADP ribose) polymerase (PARP) inhibitor, at least before monotherapy Germline…
Larotrectinib Larotrectinib is a medication for the treatment of cancer.It is an inhibitor of tropomyosin kinase receptors TrkA, TrkB, and TrkC. …
Larotrectinib Larotrectinib is a medication for the treatment of cancer.It is an inhibitor of tropomyosin kinase receptors TrkA, TrkB, and TrkC. …
Larotrectinib is a treatment for solid cancers that have a neurotrophic tyrosine receptor kinase (NTRK) gene change.…
Non-small Cell Lung Cancer Indicated for metastatic non-small cell lung cancer (NSCLC) in adults whose tumors…
Indications Olaparib is a medication for the maintenance treatment of BRCA-mutated advanced ovarian cancer in adults.…
Larotrectinib is a treatment for solid cancers that have a neurotrophic tyrosine receptor kinase (NTRK) gene change.…
Indications Olieni is a poly (ADP ribose) polymerase (PARP) inhibitor, at least before monotherapy Germline…
Indications Olaparib is a medication for the maintenance treatment of BRCA-mutated advanced ovarian cancer in…
Non-small Cell Lung Cancer Indicated for metastatic non-small cell lung cancer (NSCLC) in adults whose tumors…
Aentrek(entrectinib) is used to treat a certain type of non-small cell lung cancer (NSCLC) in adults…
Copyright © 2021-2022 LienTeh.net All rights reserved.
